China Runs Out Of Kallman Syndrome Treatments As Makers Drop Drugs
This article was originally published in PharmAsia News
China's hospitals report a shortage of key hormones for treating cases of Kallman Syndrome, which often delays puberty and affects the sense of smell.
You may also be interested in...
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
Sanofi Pasteur head David Loew has been at the heart of the company's bids to develop vaccines for COVID-19 but has decided to accept a different challenge instead and take the helm at Ipsen.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.